Celltrans, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- 11
- Market Cap
- -
- Website
- http://www.celltransinc.com
Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- CellTrans Inc.
- Registration Number
- NCT03791567
- Locations
- 🇺🇸
University of Illinois at Chicago Medical Center, Chicago, Illinois, United States
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Phase 3
Active, not recruiting
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Biological: Islets of Langerhans transplantation
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- CellTrans Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT00679042
- Locations
- 🇺🇸
University of Illinois at Chicago Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath